InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Daugherty Frank Joseph, Directeur Médical. Officer active across 1 companies, notably Greenwich LifeSciences, Inc.. Cumulatively, 5 reports have been recorded. Total volume traded: €103k. The latest transaction was disclosed on 25 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€15,1671,000 shares@ €15.16680.0040% mcap14.7% of flow
Common Stock
SEC:0001493152-22-011158:0·
Ideal exit: 20 Jan 2023 (T+270)
€17,4711,000 shares@ €17.47130.0046% mcap39.7% of flow
Common Stock
SEC:0001493152-22-001188·
Ideal exit: 10 Oct 2022 (T+270)
€17,4711,000 shares@ €17.47130.0046% mcap16.9% of flow
Common Stock
SEC:0001493152-22-001188:0·
Ideal exit: 10 Oct 2022 (T+270)
€26,5681,111 shares@ €23.91390.0070% mcap60.3% of flow
Common Stock
SEC:0001493152-21-031653·
Ideal exit: 10 Sept 2022 (T+270)
€26,5681,111 shares@ €23.91390.0070% mcap25.7% of flow
Common Stock
SEC:0001493152-21-031653:0·
Ideal exit: 10 Sept 2022 (T+270)
5 of 5 declarations
About Daugherty Frank Joseph
Frank Joseph Daugherty is the Chief Medical Officer at Greenwich LifeSciences, Inc. He is responsible for the medical and clinical aspects of the company, which focuses on developing medical treatments. Frank Joseph Daugherty plays a key role in research and development strategy.
